| __timestamp | BioCryst Pharmaceuticals, Inc. | MiMedx Group, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13486000 | 105558000 |
| Thursday, January 1, 2015 | 46361000 | 167094000 |
| Friday, January 1, 2016 | 23654000 | 212608000 |
| Sunday, January 1, 2017 | 23484000 | 285920000 |
| Monday, January 1, 2018 | 20182000 | 322725000 |
| Tuesday, January 1, 2019 | 44734000 | 256174000 |
| Wednesday, January 1, 2020 | 16136000 | 208904000 |
| Friday, January 1, 2021 | 149906000 | 215332000 |
| Saturday, January 1, 2022 | 264233000 | 219525000 |
| Sunday, January 1, 2023 | 326751000 | 266843000 |
Unleashing insights
In the ever-evolving landscape of biotechnology, the financial performance of companies can be as volatile as the innovations they pursue. From 2014 to 2023, BioCryst Pharmaceuticals and MiMedx Group have showcased contrasting trajectories in gross profit. BioCryst, with a staggering 2,320% increase from 2014 to 2023, reflects a robust growth story, peaking at $327 million in 2023. Meanwhile, MiMedx, despite a consistent performance, saw a more modest 153% rise over the same period, reaching $267 million in 2023. This divergence highlights BioCryst's aggressive expansion and strategic positioning in the market. As investors and stakeholders analyze these trends, the data underscores the importance of strategic innovation and market adaptation in the biotech sector. The journey of these two companies offers a compelling narrative of growth, resilience, and the relentless pursuit of scientific advancement.
Bristol-Myers Squibb Company vs MiMedx Group, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Vertex Pharmaceuticals Incorporated and MiMedx Group, Inc.
Key Insights on Gross Profit: Zoetis Inc. vs BioCryst Pharmaceuticals, Inc.
Gross Profit Trends Compared: Biogen Inc. vs BioCryst Pharmaceuticals, Inc.
Key Insights on Gross Profit: Catalent, Inc. vs BioCryst Pharmaceuticals, Inc.
Gross Profit Trends Compared: Walgreens Boots Alliance, Inc. vs BioCryst Pharmaceuticals, Inc.
Alkermes plc vs MiMedx Group, Inc.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Amneal Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing Amneal Pharmaceuticals, Inc. and MiMedx Group, Inc.
Who Generates Higher Gross Profit? Supernus Pharmaceuticals, Inc. or BioCryst Pharmaceuticals, Inc.
Travere Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: BioCryst Pharmaceuticals, Inc. and Evotec SE Trends